glp 1 agonist and depression The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor therapy Psychotropic effects of GLP-1R agonists

Two of the most popular GLP medications today, Wegovy and Ozempic, both have semaglutide as their active ingredient

In addition to dual GLP-1R/GIPR-targeted drugs, the development of GLP-1R/GCGR dual-target drugs and GLP-1R/GIPR/GCGR triple-target drugs is a focus of ongoing multi-target GLP-1 drug development

But it gets even more complex Third generation: GLP-1 +GIP + Glucagon Receptor Agonist Now we arrive at the triple agonistswhat some are calling GLP-3led by retatrutide

Efficacy of semaglutide versus liraglutide in clinical practice

That discontinuation rate is remarkably low for this class of drugs

Triple agonists usually cost more than proven dual agonists